Dr. Maarten Simoons

Dr. Maarten Simoons is a Professor of Cardiology (emeritus) and was Chief of Cardiology, at the Thoraxcenter, Erasmus University Medical Center in Rotterdam, the Netherlands. Professor Simoons is author of over 600 publications, mainly on management of acute coronary syndromes and preventive cardiology. He is a member of the European Society of Cardiology and was President of the Society 2000-2002. He is a member of the Taskforce on Medical Education at the Alliance for Biomedical Research in Europe. 

New industry code must safeguard independent medical education
This blog is part of the GMTCC 2018 blog series. You can follow the conversation under #GMTCC and find more details and at gmtcc.com . Check out related blogs: Swifter, Higher, Stronger: Promoting MedTech Ethics on the Global Stage, How to create and maintain an ethical culture, Global Responsibility, Global Ethics and Compliance, Global Principles for MedTech Innovation , Progress and new challenges after 10 years of collaboration, Distributors play key role in compliance and Health data can transform our lives – but must be used wisely The MedTech Code was designed by industry to ensure compliance with the highest ethical and legal standards. However, dialogue with professional medical societies is essential if we are to avoid unintended negative consequences for the quality and accessibility of education. It’s time to explore new models of collaboration Continuing medical education (CME) is a life-long commitment for clinicians. Through independently developed courses, they stay up to date with the latest scientific and technological advances in their field. Keeping doctors’ knowledge current directly benefits patients and helps developers of innovative technologies and techniques to disseminate information. CME has been successfully provided for decades through professional bodies at annual congresses and specialised seminars. As a past-President of the European Society of Cardiology and member of the Alliance for Biomedical Research in Europe ( BioMed Alliance ) – a network of 29 research-driven biomedical societies with more than 400,000 members – I have seen first-hand how professional societies support education. Congresses have attracted support from industry in a number of ways, including through unrestricted grants, and where companies cover the registration and travel costs of individual doctors. Income from these events have allowed congresses to grow; to cover a wide range of disease areas (including rare conditions); and to redeploy any surplus to other key activities...